INSPECS Group plc (AIM:SPEC)
London · Delayed Price · Currency is GBP · Price in GBX 100.00
+3.00 (3.09%)
Jul 7, 2026, 8:00 AM GMT
INSPECS Group Market Cap
INSPECS Group has a market cap or net worth of 98.62 million as of July 7, 2026. Its market cap has increased by 97.96% in one year.
Market Cap
98.62M
Enterprise Value
142.41M
Revenue
191.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
100.00
Market Cap Chart
Since February 27, 2020, INSPECS Group's market cap has decreased from 137.95M to 98.62M, a decrease of -28.51%. That is a compound annual growth rate of -5.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 98.62M | 35.66% |
| Dec 31, 2025 | 72.70M | 57.14% |
| Dec 31, 2024 | 46.26M | -45.83% |
| Dec 29, 2023 | 85.40M | 95.35% |
| Dec 30, 2022 | 43.72M | -88.33% |
| Dec 31, 2021 | 374.78M | 12.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 224.22B |
| GSK plc | 80.29B |
| Haleon | 32.12B |
| Smith & Nephew | 9.56B |
| Diaceutics | 123.62M |
| EKF Diagnostics Holdings | 113.22M |
| Faron Pharmaceuticals Oy | 94.23M |
| Bioventix | 83.60M |